- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Johnson & Johnson (JNJ) Target Of FDA Wrath
Recent Articles by Ed Liston
- Lehman Case Shows Audit Firms Still Putting Client’s Interest Ahead Of Investors (WMT, COP, TGT)
- ICx Technologies, Inc. (ICXT) Reports Fourth-Quarter Results
- John Thain Plans To Retain CIT Group’s (CIT) Aircraft Finance Unit
- William Lynch Becomes New Barnes & Noble (BKS) CEO
- Greece Is Not Seeking Financial Aid From Either EU Or IMF; George Papandreou
Company News
- Lehman Case Shows Audit Firms Still Putting Client’s Interest Ahead Of Investors (WMT, COP, TGT)
- ICx Technologies, Inc. (ICXT) Reports Fourth-Quarter Results
- John Thain Plans To Retain CIT Group’s (CIT) Aircraft Finance Unit
- Perry Ellis Earnings Preview (PERY)
- William Lynch Becomes New Barnes & Noble (BKS) CEO
FDA
- FDA Approves Medtronic (MDT) Diabetes Management System
- Boston Scientific Corporation (BSX) Options Active On Positive FDA Data
- Boston Scientific Corp. Halts Sale Of ICDs (BSX)
- Amylin Shooting Higher
- Medtronic (MDT) Gets FDA Approval For Epilepsy Treatment
Markets
- Lehman Case Shows Audit Firms Still Putting Client’s Interest Ahead Of Investors (WMT, COP, TGT)
- ICx Technologies, Inc. (ICXT) Reports Fourth-Quarter Results
- John Thain Plans To Retain CIT Group’s (CIT) Aircraft Finance Unit
- William Lynch Becomes New Barnes & Noble (BKS) CEO
- CRA International (CRAI) Plummets Nearly 20%
Posted on 01/18/10 at 12:14pm by Ed Liston
McNeil-PPC, a Johnson & Johnson (NYSE: JNJ) division, has kicked off a broad based recall of approximately 500 lots of drugs like Tylenol, Motrin, and Benadryl.
The recall, announced on Friday, drew the wrath of the FDA on Johnson & Johnson for not acting fast enough on complaints of a moldy, mildew-like odor on their drugs.
The problem first surfaced in early 2008, but the company identified it as an ‘issue’ only in September 2008. The FDA has issued a warning letter to McNeil stating that failure to rectify the problem could result in legal action and seizure.
The company received a number of complaints of stomach problems, which it has traced to a chemical applied on wooden pallets used in the transport of drugs. McNeil started recalling lots in November 2009.
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
Related News from the Stock Market
- This Healthcare ETF (XLV) Is Seeing Above Average Call Buying
- Investors Are Turning To Small and Mid Cap ETFs In 2010
- Health Care ETF Draws Bearish Trade
- Goldman Sachs (GS) VIP List of Top Hedge Fund Holdings
- Top 5 NYSE Stocks In The Healthcare Sector With The Highest Dividend (ACL, AZN, GSK, NVS, JNJ)
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
